Aptose Biosciences Inc. (NASDAQ: APTO)
$0.71
-0.0004 ( -0.06% ) 79.5K
Aptose Biosciences Inc is a clinical-stage biotechnology company committed to discovering and developing personalized therapies addressing unmet medical needs in oncology. The Company's small molecule cancer therapeutics pipeline includes products designed to provide single agent efficacy and to enhance the efficacy of other anti-cancer therapies and regimens without overlapping toxicities.
Market Data
Open
$0.71
Previous close
$0.71
Volume
79.5K
Market cap
$12.73M
Day range
$0.69 - $0.73
52 week range
$0.67 - $5.10
SEC Fillings
Form Type | Description | Pages | Date |
---|---|---|---|
4 | Insider transactions | 1 | May 10, 2024 |
8-k | 8K-related | 15 | May 06, 2024 |
8-k | 8K-related | 20 | May 01, 2024 |
pre | Proxies and info statements | 6 | Apr 30, 2024 |
10-k/a | Quarterly Reports | 17 | Apr 29, 2024 |
8-k | 8K-related | 14 | Apr 26, 2024 |
8-k | 8K-related | 13 | Apr 05, 2024 |
8-k | 8K-related | 15 | Mar 26, 2024 |
10-k | Annual reports | 88 | Mar 26, 2024 |
8-k | 8K-related | 15 | Mar 18, 2024 |